Dosimetric advantages of a “butterfly” technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin’s lymphoma

[1]  S. Tofani,et al.  Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin’s lymphoma: dosimetric comparison and clinical considerations , 2012, Radiation oncology.

[2]  P. Iyengar,et al.  Radiation for Hodgkin's lymphoma in young female patients: a new technique to avoid the breasts and decrease the dose to the heart. , 2011, International journal of radiation oncology, biology, physics.

[3]  L. Cozzi,et al.  Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients. , 2010, International journal of radiation oncology, biology, physics.

[4]  R. Greil,et al.  Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. , 2010, The New England journal of medicine.

[5]  A. Broeks,et al.  Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  L. Robison,et al.  Radiation dose and breast cancer risk in the childhood cancer survivor study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  A. Ng,et al.  Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose. , 2008, International journal of radiation oncology, biology, physics.

[8]  Philip Hahnfeldt,et al.  Second cancers after fractionated radiotherapy: stochastic population dynamics effects. , 2007, Journal of theoretical biology.

[9]  D. Brenner,et al.  Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma , 2007, Cancer.

[10]  Hans-Jörg Kraus,et al.  Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases , 2006, Radiation oncology.

[11]  J. Raemaekers,et al.  Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  E. Noordijk,et al.  Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  Georges Noël,et al.  Conformity index: a review. , 2006, International journal of radiation oncology, biology, physics.

[14]  G. Bonadonna,et al.  ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Dirk Hasenclever,et al.  Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Stovall,et al.  Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. , 2003, JAMA.

[17]  A. Broeks,et al.  Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. , 2003, Journal of the National Cancer Institute.

[18]  Aamer Chughtai,et al.  Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. , 2011, International journal of radiation oncology, biology, physics.

[19]  C. Lawton.  Breast Cancer Risk in Female Survivors of Hodgkin'S Lymphoma: Lower Risk After Smaller Radiation Volumes , 2010 .

[20]  E. Glatstein.  Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines , 2008 .